IMNN
Imunon Inc
NASDAQ: IMNN · HEALTHCARE · BIOTECHNOLOGY
$2.83
+5.60% today
Updated 2026-04-30
Market cap
$10.98M
P/E ratio
—
P/S ratio
17.94x
EPS (TTM)
$-6.83
Dividend yield
—
52W range
$3 – $36
Volume
0.1M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D4.0
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$19.20
+578.45%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.66M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $500000.00 | $125000.00 | $0.00 | $0.00 | $125000.00 |
| Net income | $-35.90M | $-19.51M | $-18.62M | $-14.49M | $-4.22M |
| EPS | — | — | — | — | $-6.83 |
| Free cash flow | $-23.36M | $-19.47M | $-18.88M | $-14.18M | $-3.66M |
| Profit margin | -7,179.65% | -15,611.98% | — | — | — |
Peer comparison
Smart narrative
Imunon Inc trades at $2.83. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $125000.00.
Frequently asked questions
What is Imunon Inc's stock price?
Imunon Inc (IMNN) trades at $2.83.
Is Imunon Inc overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of Imunon Inc (IMNN)?
The analyst target price is $19.20, representing +578.4% upside from the current price of $2.83.
What is Imunon Inc's revenue?
TTM revenue is $125000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio17.94x
ROE-256.40%
Beta2.12
50D MA$3.07
200D MA$4.44
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—